This page lists the gynaecology hospitals in our directory offering Tubal Ligation Reversal in Mumbai, India, including Nanavati Super Specialty Hospital, Kokilaben Dhirubhai Ambani Hospital, Tata Memorial Hospital, Apollo Hospitals, Navi Mumbai and others. Each listing links through to the hospital's full profile page.
Ask us about tubal ligation reversal in Mumbai, India
Share a few details and our care coordination team will get back to you with next steps.
Compare 17 accredited hospitals for Gynaecology in Mumbai, India
Featured🇮🇳 Nanavati Super Specialty Hospital
Ranks #1 in this list by listed rating (5/5 from 12 reviews).
🇮🇳 Kokilaben Dhirubhai Ambani Hospital
Ranks #2 in this list by listed rating (4.8/5 from 1800 reviews).
🇮🇳 Tata Memorial Hospital
Ranks #3 in this list by listed rating (4.8/5 from 2500 reviews).
🇮🇳 Apollo Hospitals, Navi Mumbai
Ranks #4 in this list by listed rating (4.8/5 from 512 reviews).
🇮🇳 Gleneagles Hospital, Mumbai
Ranks #5 in this list by listed rating (4.8/5 from 615 reviews).
🇮🇳 Lilavati Hospital And Research Centre
Ranks #6 in this list by listed rating (4.8/5 from 724 reviews).
🇮🇳 Jaslok Hospital
Ranks #7 in this list by listed rating (4.6/5 from 129 reviews).
🇮🇳 Gleneagles Global Hospitals (Global Hospitals)
Ranks #8 in this list by listed rating (4.6/5 from 183 reviews).
🇮🇳 Medicover Hospital, Navi Mumbai
Ranks #9 in this list by listed rating (4.6/5 from 143 reviews).
🇮🇳 KIMS Hospitals, Thane
Ranks #10 in this list by listed rating (4.6/5 from 58 reviews).
🇮🇳 Fortis Hospital, Mulund
Ranks #11 in this list by listed rating (4.5/5 from 79 reviews).
🇮🇳 Fortis Hiranandani Hospital, Vashi
Ranks #12 in this list by listed rating (4.5/5 from 83 reviews).
🇮🇳 Wockhardt Hospital
Ranks #13 in this list by listed rating (4.4/5 from 30 reviews).
🇮🇳 Wockhardt Super Speciality Hospital
Ranks #14 in this list by listed rating (4.4/5 from 48 reviews).
🇮🇳 S. L. Raheja Hospital
Ranks #15 in this list by listed rating (4.4/5 from 121 reviews).
🇮🇳 Saifee Hospital
Ranks #16 in this list by listed rating (4.3/5 from 97 reviews).
🇮🇳 Dr. L H Hiranandani Hospital
Ranks #17 in this list by listed rating (4.3/5 from 141 reviews).
How we selected these hospitals
A hospital appears on this page when Gynaecology is among its listed specialties and it is located in Mumbai, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How to Select the Best Hospital for Tubal Ligation Reversal in Mumbai, India?
Choosing the right hospital for tubal ligation reversal is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:
International Accreditation
Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.
Specialization
Check that the hospital's listed specialties actually include gynaecology rather than only general care.
Capacity and Track Record
Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.
Transparent Costs
Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.
Understanding Tubal Ligation Reversal
Tubal ligation reversal (tubal reanastomosis) is a microsurgical procedure that reconnects the fallopian tubes after a previous sterilization, restoring natural fertility with pregnancy rates ranging from 40% to 85% depending on patient age, tube length remaining, and the original ligation technique. India and the UAE have emerged as premier destinations for this procedure, offering world-class microsurgical and robotic-assisted expertise at a fraction of Western costs, with GAF Healthcare coordinating every step of the international patient journey — from diagnostic evaluation to post-operative follow-up. Hospital Stay: 1–2 days (laparoscopic/robotic); 2–3 days (open microsurgery) • Total Stay in Country (Fit-to-Fly): 2–3 weeks (short-haul); 3–4 weeks (long-haul intercontinental flights) • Success Rate: 40%–85% cumulative pregnancy rate within 24 months (age and tubal length dependent)
Clinical Overview
Tubal ligation reversal, formally termed tubal reanastomosis or microsurgical tubal reconstruction, restores patency to the fallopian tubes that were previously occluded, cut, or removed in segments during sterilization. The procedure is physiologically significant because the fallopian tube is not merely a passive conduit — its ciliated epithelium, peristaltic musculature, and secretory environment are critical for oocyte capture, sperm transport, fertilization, and early embryo development. When tubal continuity is surgically restored, this entire functional micro-environment can be re-established, enabling natural conception without assisted reproductive technology. The original sterilization method is the single greatest determinant of reversal feasibility and success. Methods such as Filshie clips or Falope rings cause minimal tubal damage and are associated with the highest reversal success rates (up to 80–85%), as they preserve maximum tubal length. In contrast, Pomeroy ligation, electrocautery fulguration, and salpingectomy (complete tube removal) result in greater tissue loss, leaving shorter or absent tubal segments that significantly reduce or eliminate reversal candidacy. The critical anatomical parameter is the remaining tubal length: a minimum of 4 cm of healthy, patent tube on each side is generally required to achieve a functional anastomosis. The current standard of care combines high-resolution preoperative imaging (hysterosalpingography or saline infusion sonography) with microsurgical technique under optical magnification — either surgical loupes (×4–×6) or robotic assistance (da Vinci Surgical System) — to achieve a tension-free, well-vascularized, lumen-to-lumen anastomosis using fine absorbable sutures (6-0 or 7-0 polyglactin). Leading centers in India and the UAE routinely incorporate robotic-assisted laparoscopic tubal reanastomosis, which offers three-dimensional magnification, tremor filtration, and superior instrument articulation compared to conventional laparoscopy, translating into superior anastomotic precision.
Who is a Candidate?
• IDEAL CANDIDATES: • Women under 37 years of age (highest pregnancy rates; acceptable candidacy up to age 42 with thorough counseling) • Minimum 4 cm of healthy fallopian tube remaining bilaterally, confirmed on hysterosalpingography (HSG) or diagnostic laparoscopy • Original sterilization by clip (Filshie/Hulka), ring (Falope), or Pomeroy technique (not fulguration to the cornua or salpingectomy) • Normal ovarian reserve: Anti-Müllerian Hormone (AMH) ≥ 1.0 ng/mL, Antral Follicle Count (AFC) ≥ 7, Day-3 FSH < 10 mIU/mL • Normal uterine cavity confirmed by saline infusion sonography (SIS) or hysteroscopy — absence of fibroids, polyps, or Asherman's syndrome • Partner with confirmed normal semen analysis (WHO 2021 reference criteria): concentration ≥ 16 million/mL, motility ≥ 42%, morphology ≥ 4% normal forms • BMI < 35 kg/m² (obesity increases anesthetic risk and reduces surgical visualization) • No active pelvic inflammatory disease (PID), endometriosis stage III/IV, or extensive pelvic adhesions • REQUIRED PREOPERATIVE DIAGNOSTICS: • Hysterosalpingography (HSG) — to map the proximal tubal stump length and assess uterine cavity • Transvaginal ultrasound with antral follicle count (AFC) • Hormonal panel: AMH, Day-3 FSH, LH, Estradiol, Prolactin, TSH • Complete blood count, coagulation profile (PT/INR/aPTT), renal and hepatic function tests • Infectious disease screening: HIV, Hepatitis B surface antigen, Hepatitis C antibody, VDRL/RPR • Pap smear within last 3 years (or repeat if overdue) • Partner semen analysis • Diagnostic laparoscopy (in select cases where HSG is inconclusive regarding distal tube status) • CONTRAINDICATIONS (ABSOLUTE): • Prior bilateral salpingectomy (no tubal remnant available for anastomosis) • Remaining tubal length < 2 cm bilaterally after anticipated resection of damaged segments • Severely compromised ovarian reserve (AMH < 0.5 ng/mL, FSH > 15 mIU/mL) where IVF offers superior outcomes • Active malignancy of the reproductive tract • Uncontrolled medical comorbidities precluding general anesthesia • Partner with azoospermia or severe oligo-asthenoteratozoospermia unresponsive to treatment • RELATIVE CONTRAINDICATIONS (REQUIRE INDIVIDUALIZED COUNSELING): • Age ≥ 40 years (pregnancy rates fall to 30–40%; IVF comparison counseling mandatory) • Electrocautery sterilization with extensive cornual involvement • Prior ectopic pregnancy history (elevated risk of repeat ectopic post-reversal) • Endometriosis stage I/II (managed surgically at time of reversal if feasible)
Treatment Options & Approaches
SURGICAL APPROACHES TO TUBAL REANASTOMOSIS: 1. ROBOTIC-ASSISTED LAPAROSCOPIC TUBAL REANASTOMOSIS (RALTR) — MOST ADVANCED: Using the da Vinci Xi or da Vinci SP Surgical System, this approach provides 10× to 15× three-dimensional magnification, 7 degrees of freedom with EndoWrist instrumentation, and active tremor filtration. The surgeon performs the anastomosis with 6-0 or 7-0 polyglactin (Vicryl) sutures in a two-layer technique (muscularis and serosa separately) under superior optical clarity. RALTR is now the preferred approach at centers of excellence in both India and the UAE. It carries the advantages of minimally invasive surgery (smaller incisions, less blood loss, faster recovery) combined with microsurgical precision previously achievable only via laparotomy. Operating time: 90–150 minutes. 2. CONVENTIONAL LAPAROSCOPIC TUBAL REANASTOMOSIS: Performed with standard laparoscopic instruments and surgical loupes or camera magnification. Technically demanding due to the two-dimensional view and reduced instrument dexterity compared to robotic assistance. Suitable for experienced minimally invasive gynecological surgeons. Shorter operative time in experienced hands (60–120 minutes). Increasingly being replaced by RALTR at high-volume centers. 3. OPEN MICROSURGICAL TUBAL REANASTOMOSIS (MINI-LAPAROTOMY): Historically the gold standard, performed through a Pfannenstiel incision with the operating microscope (×8–×25 magnification) and microsurgical instruments (jewelers' forceps, micro-scissors). A two-layer anastomosis is created — mucosal layer with 7-0 nylon or polyglactin, followed by musculoserosal layer with 6-0 polyglactin. Despite higher invasiveness, this approach remains relevant when robotic equipment is unavailable or when extensive peritubal adhesiolysis is required simultaneously. Published pregnancy rates are comparable to RALTR when performed by expert microsurgeons. 4. ANASTOMOTIC TECHNIQUES BY SEGMENT: • Isthmo-isthmic anastomosis: Best outcomes (both segments are narrow-caliber, similar diameter). Pregnancy rates 75–85%. • Isthmo-ampullary anastomosis: Good outcomes; diameter mismatch is managed by spatulating the narrower segment. • Ampullo-ampullary anastomosis: Acceptable outcomes when adequate length remains. • Cornual (interstitial) implantation: Reserved for cases with proximal occlusion at the uterine cornua; technically complex, lower success rates. 5. ADJUNCT PROCEDURES PERFORMED SIMULTANEOUSLY: • Adhesiolysis for pelvic adhesions • Laparoscopic treatment of incidentally found endometriosis implants • Ovarian cystectomy (if a benign cyst is identified) • Chromopertubation: Blue dye instilled transcervically at the conclusion of surgery to confirm tubal patency before closing 6. TUBAL REVERSAL vs. IN VITRO FERTILIZATION (IVF) — DECISION FRAMEWORK: For women under 37 with good ovarian reserve and favorable anatomy, tubal reversal offers cumulative pregnancy rates that equal or exceed a single IVF cycle at significantly lower total cost, with the added benefit of multiple natural conception attempts. For women over 40, those with poor ovarian reserve, or those with salpingectomy, IVF is the evidence-based recommendation. GAF Healthcare's fertility specialists provide individualized decision consultations comparing both pathways.
Recovery
PHASE 1 — REMOTE PRE-CONSULTATION (4–6 weeks before travel): • Submit medical records to GAF Healthcare: operative report from original tubal ligation, any prior pelvic surgery reports, HSG films or reports, recent hormonal panel results, and partner semen analysis • GAF Healthcare assigns a dedicated Patient Coordinator who facilitates a video consultation with the treating gynecologist/reproductive surgeon within 48–72 hours of document submission • Surgeon reviews tubal ligation technique, estimates remaining tubal length, and provides a candidacy assessment and success rate estimate specific to the patient • Multidisciplinary review includes a reproductive endocrinologist if ovarian reserve parameters require discussion • If HSG has not been performed, it is scheduled locally or on arrival depending on availability PHASE 2 — ARRIVAL AND PRE-OPERATIVE WORKUP (Days 1–2 in country): • Airport pickup by GAF Healthcare ground team; transfer to partner hospital or serviced accommodation • Day 1: Hospital admission for pre-operative assessment — blood tests (if not done remotely), anesthesia consultation, pelvic ultrasound with AFC, and final surgical planning conference with the operating surgeon • Day 2 (morning of surgery): NPO (nil per os) from midnight; pre-operative medications administered; written informed consent obtained with the assistance of a GAF Healthcare medical interpreter if required • Anesthesia: General endotracheal anesthesia with multimodal analgesia (opioid-sparing protocol using dexamethasone, ketorolac, and ondansetron) PHASE 3 — THE SURGICAL PROCEDURE (Day 2 or 3, 2–3 hours including setup): • Laparoscopic or robotic port placement (typically 4 ports for robotic; 3 ports for laparoscopic) • Systematic pelvic survey to assess adhesions, endometriosis, ovarian status, and tubal stumps • Identification and excision of damaged/occluded tubal segments back to healthy, bleeding tissue • Microsurgical or robotic two-layer anastomosis performed under magnification with fine absorbable sutures • Chromopertubation with methylene blue or indigo carmine to confirm patency bilaterally • Port closure and skin closure; procedure complete in 90–150 minutes for robotic/laparoscopic PHASE 4 — IMMEDIATE POST-OPERATIVE RECOVERY (Day 2–4, in hospital): • Recovery room observation for 2–4 hours post-anesthesia • Ambulation encouraged on the evening of surgery (laparoscopic/robotic cases) • Oral analgesia: acetaminophen (paracetamol) + ibuprofen scheduled, with tramadol or low-dose opioids available PRN • Antibiotic prophylaxis: single-dose cefazolin intraoperatively; extended oral course if adhesiolysis was extensive • Anti-thrombotic prophylaxis: LMWH (enoxaparin) for high-risk patients; compression stockings for all patients • Discharge criteria: tolerating oral diet, pain controlled on oral medications, no fever, no signs of surgical site complications • Laparoscopic/robotic patients: discharged Day 1–2 post-op; open (mini-laparotomy) patients: discharged Day 2–3 post-op PHASE 5 — IN-COUNTRY RECOVERY PERIOD (Week 1–3 after surgery): • Days 3–7: Rest at accommodation; mild walking encouraged; avoid lifting > 5 kg, strenuous activity, and sexual intercourse • Day 7: Post-operative wound check and suture inspection (absorbable sutures do not require removal); surgical and nursing review • Week 2: Gradual return to light activity; most patients report resolution of post-operative bloating and shoulder tip pain (from residual CO₂) by Day 4–5 • Week 2–3: Final pre-departure consultation with the surgeon; confirmation of wound healing and absence of complications; written discharge summary, surgical report, and post-operative instructions provided PHASE 6 — FIT-TO-FLY CLEARANCE AND DEPARTURE: • Laparoscopic/robotic cases: Cleared for short-haul flights (< 4 hours) at 2 weeks; intercontinental flights (> 6 hours) at 3 weeks with compression stockings and in-flight ambulation instructions • Open microsurgery cases: Cleared for short-haul at 3 weeks; intercontinental at 4 weeks • DVT prevention: All patients prescribed LMWH or oral anticoagulant for flights > 4 hours post-gynecological surgery PHASE 7 — POST-DEPARTURE FOLLOW-UP AND TTC GUIDANCE: • Avoid attempting to conceive for the first menstrual cycle following surgery to allow tubal healing • Begin trying to conceive (TTC) from the second post-operative menstrual cycle • Monthly pregnancy tests from Month 2 onward; early ultrasound at 6–7 weeks gestation to confirm intrauterine location (ectopic pregnancy risk is elevated at 5–10% post-reversal vs. 1–2% in the general population) • If no natural conception after 12 months of TTC (or 6 months for women > 37), transition to IVF is recommended • GAF Healthcare provides telemedicine follow-up at 6 weeks, 3 months, 6 months, and 12 months post-operatively
Risks to be aware of
Tubal ligation reversal is a well-tolerated procedure with an excellent safety profile when performed by an experienced reproductive or gynecological microsurgeon at an accredited center, but patients must be comprehensively counseled on the following specific risks: SURGICAL AND ANESTHETIC RISKS: General anesthesia carries standard risks including adverse drug reactions, aspiration, and rare cardiovascular events. Intraoperative risks include inadvertent injury to adjacent structures (bowel, bladder, ureter, iliac vessels), though these are uncommon (< 1%) in elective laparoscopic gynecological surgery at high-volume centers. Hemorrhage requiring conversion from laparoscopic to open surgery occurs in < 2% of cases. ECTOPIC PREGNANCY (TUBAL PREGNANCY): The most clinically significant post-reversal risk. The damaged or reconstructed fallopian tube may transport the fertilized oocyte suboptimally, resulting in implantation within the tube rather than the uterus. The ectopic pregnancy rate following tubal reversal is 5–10%, compared with 1–2% in the general fertile population. All patients must be instructed to undergo transvaginal ultrasound at 6–7 weeks of any subsequent pregnancy to confirm intrauterine location. Unrecognized ectopic pregnancy can result in tubal rupture, hemorrhage, and life-threatening emergency — patients must be educated on warning symptoms: unilateral pelvic pain, vaginal bleeding, shoulder tip pain, or dizziness in early pregnancy. FAILURE TO ACHIEVE PATENCY: Chromopertubation at surgery may confirm initial patency, but scar tissue formation during healing (re-occlusion) can occur in up to 10–15% of anastomoses. Postoperative HSG at 3 months is recommended if natural conception has not occurred to confirm ongoing patency. PELVIC ADHESION FORMATION: All intraperitoneal surgery carries a risk of de novo adhesion formation, which may affect tubal function or cause pelvic pain. Use of adhesion barriers (Interceed, Seprafilm) is at the surgeon's discretion based on intraoperative findings. FAILURE TO CONCEIVE (PROCEDURE SUCCESS ≠ PREGNANCY GUARANTEE): A technically successful anastomosis does not guarantee pregnancy. Factors beyond tubal anatomy — ovarian reserve decline, endometrial receptivity, sperm quality, and age-related oocyte aneuploidy — all influence the final reproductive outcome. Patients aged > 40 should be explicitly counseled that IVF may offer higher per-cycle success rates than natural conception post-reversal.
Why GAF Healthcare
GAF Healthcare provides an end-to-end medical tourism coordination service that eliminates the administrative burden of international medical travel, ensuring patients can focus entirely on their health and recovery. VISA AND ENTRY DOCUMENTATION — INDIA: GAF Healthcare facilitates the Indian e-Medical Visa (e-MV) application, which permits stays of up to 60 days (extendable) specifically for medical treatment and is available to nationals of 156 eligible countries. Our team prepares and reviews the application package — including the official hospital invitation letter from the treating institution, diagnostic and appointment confirmations, and the online MHA portal submission — typically achieving approval within 3–5 business days. The e-Medical Visa also allows one attendant (companion) on a concurrent e-Medical Attendant Visa (e-MAtv). Our team monitors approval status and provides pre-travel documentation checklists. VISA AND ENTRY DOCUMENTATION — UAE (DUBAI / ABU DHABI): The UAE operates one of the world's most accessible entry frameworks for medical tourists. Nationals of GCC countries, EU member states, the United Kingdom, the United States, Canada, Australia, and approximately 50 additional countries are granted visa-free entry or visa-on-arrival for 30–90 days. For nationalities requiring a pre-arranged visa, GAF Healthcare coordinates the UAE medical treatment visa application through its Dubai and Abu Dhabi hospital partners. Dubai Health Authority (DHA) and Department of Health Abu Dhabi (DoH) licensed facilities issue the required medical treatment confirmation letters. AIRPORT AND GROUND TRANSFERS: Dedicated meet-and-greet service at the international arrival terminals of all major partner airports (Delhi IGI, Mumbai CSIA, Chennai MAA, Dubai DXB, Abu Dhabi AUH). Transfers are in clean, air-conditioned vehicles with a GAF Healthcare ground team member present for direct communication. Wheelchair and ambulatory assistance is arranged in advance for patients with mobility limitations. MEDICAL INTERPRETATION AND TRANSLATION: GAF Healthcare maintains a roster of qualified medical interpreters fluent in Arabic, Russian, French, Swahili, Bangla, and other major international patient languages. Interpreters accompany patients during surgical consultations, pre-operative consent discussions, and post-operative discharge briefings to ensure clinical information is conveyed accurately and that patients can ask questions in their native language without ambiguity. ACCOMMODATION FOR PATIENTS AND ATTENDANTS: GAF Healthcare partners with serviced apartments, patient guest houses, and hotels within 5–15 minutes of each partner hospital, providing furnished accommodation suitable for the 2–3 week in-country recovery stay. Options are available across budget tiers (standard to premium). Attendant accommodation is arranged concurrently, ensuring the patient's companion is housed in the same building or complex. Meal delivery, housekeeping, and 24-hour emergency contact with the GAF Healthcare Patient Coordinator are standard inclusions. CONTINUITY OF CARE AND REMOTE FOLLOW-UP: Following departure, GAF Healthcare remains the communication bridge between the patient and the treating surgical team. All operative reports, histopathology results, discharge summaries, and post-operative prescriptions are digitized and shared via a secure patient portal. Telemedicine follow-up appointments are scheduled at 6 weeks, 3 months, and 6 months post-surgery, enabling the treating surgeon to review wound healing, discuss pregnancy attempt timelines, and order any remote investigations (such as post-operative HSG) through GAF Healthcare's network of partner laboratories in the patient's home country.
Common questions about Tubal Ligation Reversal
What is the cost of tubal ligation reversal in India compared to the UAE?
How long do I need to stay in India or the UAE before I am fit to fly home after tubal ligation reversal?
What is the success rate of tubal ligation reversal, and what factors affect my chances of pregnancy?
Related pages
How GAF Healthcare Assists in Choosing the Best Hospital for Tubal Ligation Reversal in Mumbai, India
Discover the Top Hospitals for Tubal Ligation Reversal in Mumbai, India
This page lists 17 accredited gynaecology hospitals in Mumbai, India, so you can compare accreditation, specialties and bed capacity in one place.
Support When You Need It Most
Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.
Transparent, All-Inclusive Costs
We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.
Visa, Travel and Stay Coordination
Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.
Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.
Frequently asked questions about tubal ligation reversal in Mumbai, India
How many gynaecology hospitals are listed in Mumbai, India?
How do you choose which hospitals to list?
How much does treatment cost in India?
Are there gynaecology hospitals for this in other India cities?
Next Step
Share your medical reports with us and our team will recommend a hospital and treatment plan for tubal ligation reversal in Mumbai, India.
Contact us to report an inaccuracy on this page.